Bionest

ASCO 2020: Part 2

In our second ASCO highlights post, we discuss the promising potential of liquid biopsy and comprehensive genotyping in precision oncology, and new indications for Keytruda.

Bionest

ASCO 2020: Part 1

In our first of two ASCO 2020 posts, we discuss clinical data from an off-the-shelf CAR-T therapy, and look at how real-world evidence can be used to help physicians improve outcomes for their cancer patients in ways beyond cancer treatment itself.